The global ageing of the population creates a growing demand for advanced diagnostic tools that will address a large number of challenges for disease diagnosis, prognosis, and treatment. Biological imaging techniques are highly attractive for this purpose as they allow one to visualize different objects (such as tumors) or processes (such as the variation of metabolites) and obtain precise information at the molecular and anatomical levels. In addition, recent advances in instrumentation and in the development of innovative imaging modalities have revolutionized the field of medical and biological detection, drastically improving the possibilities and accuracies of fast screening, diagnosis, prediction and treatment. For example, real-time optical image-guided surgery, the monitoring of drug delivery, the precise detection of tumour boundaries or tumour infiltration patterns, and the early detection of numerous different diseases have become feasible. However, to take full advantage of all these advanced technological developments, it is crucial to design innovative, versatile imaging agents that will address all the specific requirements of a particular biological need.
This multidisciplinary meeting will bring together experts in the design, chemical synthesis and characterization of molecular and nanosized imaging agents with biologists and medical doctors who will benefit from them for innovative biological and clinical imaging. The topics will cover:
- Peculiarities of the design, synthesis and characterization of molecular and nanosized imaging agents;
- Optical imaging and sensing applications;
- Biological imaging;
- Clinical imaging.
👉This project is co-financed by the Loire Val-Health project, funded by the ANR and France 2030 under the number ANR-23-EXES-0007.
Convenors
Vincent Pecoraro, LE STUDIUM Research Professor
FROM University of Michigan - USA
IN RESIDENCE AT Center for Molecular Biophysics (CBM)/CNRS - FR
Svetlana Eliseeva & Stéphane Petoud
Center for Molecular Biophysics (CBM)/CNRS - FR
